Craig Michael Bowe,John Christopher Carter,Dana Elaine Moseson,Stephen Paul Levine
申请号：
US16119362
公开号：
US10555907B2
申请日:
2018.08.31
申请国别(地区):
US
年份:
2020
代理人:
摘要：
Described are controlled-release solid dosage forms of mesalamine. In one aspect of the invention the controlled-released solid dosage forms of mesalamine are capsules comprising a plurality of coated mini-tablets. Another aspect of the invention related to a methods of treating a patient suffering from inflammatory bowel disease, comprising the step of administering to the patient a therapeutically effective amount of the solid dosage form. The invention also relates to methods of inducing remission of inflammatory bowl disease and maintaining remission of inflammatory bowel disease. In certain aspects, the inflammatory bowel disease is ulcerative colitis or Crohn's disease.
